|
|||||
|
|
| Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter
|
| Ticker | Owner | Relationship | Date | Transaction | Cost |
#Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| CPRX | Del Carmen Jeffrey | Chief Commercial Officer | Nov 26 '25 | Option Exercise | 4.21 | 10,983 | 46,238 | 14,945 | Nov 28 05:00 PM |
| CPRX | Del Carmen Jeffrey | Chief Commercial Officer | Nov 26 '25 | Sale | 23.33 | 10,983 | 256,244 | 3,962 | Nov 28 05:00 PM |
| CPRX | Del Carmen Jeffrey | Officer | Nov 26 '25 | Proposed Sale | 23.33 | 10,983 | 256,247 | Nov 26 01:54 PM | |
| CPRX | Del Carmen Jeffrey | Chief Commercial Officer | Mar 03 '25 | Sale | 22.89 | 30,423 | 696,382 | 0 | Mar 05 05:00 PM |
| CPRX | Del Carmen Jeffrey | Officer | Mar 03 '25 | Proposed Sale | 22.89 | 30,423 | 696,382 | Mar 03 10:21 AM | |
| CPRX | Del Carmen Jeffrey | Chief Commercial Officer | Aug 09 '24 | Option Exercise | 2.86 | 30,000 | 85,800 | 42,369 | Aug 13 05:01 PM |
| CPRX | Del Carmen Jeffrey | Chief Commercial Officer | Aug 09 '24 | Sale | 18.42 | 36,058 | 664,310 | 12,369 | Aug 13 05:01 PM |
| CPRX | Del Carmen Jeffrey | Officer | Aug 09 '24 | Proposed Sale | 18.42 | 36,058 | 664,348 | Aug 09 11:24 AM | |
| CPRX | Del Carmen Jeffrey | Chief Commercial Officer | Jun 07 '24 | Sale | 16.07 | 7,541 | 121,184 | 18,427 | Jun 11 05:00 PM |
| CPRX | Del Carmen Jeffrey | Chief Commercial Officer | Mar 29 '23 | Option Exercise | 3.18 | 40,000 | 127,063 | 28,524 | Mar 30 05:01 PM |
| CPRX | Del Carmen Jeffrey | Chief Commercial Officer | Mar 29 '23 | Sale | 16.70 | 40,000 | 667,810 | 7,541 | Mar 30 05:01 PM |
| CPRX | Del Carmen Jeffrey | Chief Commercial Officer | Nov 11 '22 | Option Exercise | 2.78 | 139,017 | 385,798 | 120,000 | Nov 15 05:00 PM |
| CPRX | Del Carmen Jeffrey | Chief Commercial Officer | Nov 11 '22 | Sale | 16.12 | 139,017 | 2,241,382 | 0 | Nov 15 05:00 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite